Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential  for therapeutic intervention Kogan M; Rappaport JRetrovirology  2011[Apr]; 8 (ä): 25The HIV protein, Vpr, is a multifunctional accessory protein critical for  efficient viral infection of target CD4+ T cells and macrophages. Vpr is  incorporated into virions and functions to transport the preintegration complex  into the nucleus where the process of viral integration into the host genome is  completed. This action is particularly important in macrophages, which as a  result of their terminal differentiation and non-proliferative status, would be  otherwise more refractory to HIV infection. Vpr has several other critical  functions including activation of HIV-1 LTR transcription, cell-cycle arrest due  to DCAF-1 binding, and both direct and indirect contributions to T-cell  dysfunction. The interactions of Vpr with molecular pathways in the context of  macrophages, on the other hand, support accumulation of a persistent reservoir of  HIV infection in cells of the myeloid lineage. The role of Vpr in the virus life  cycle, as well as its effects on immune cells, appears to play an important role  in the immune pathogenesis of AIDS and the development of HIV induced end-organ  disease. In view of the pivotal functions of Vpr in virus infection, replication,  and persistence of infection, this protein represents an attractive target for  therapeutic intervention.|Animals[MESH]|HIV Infections/immunology/therapy/*virology[MESH]|HIV/genetics/*metabolism/pathogenicity[MESH]|Humans[MESH]|vpr Gene Products, Human Immunodeficiency Virus/antagonists &  inhibitors/genetics/*metabolism[MESH] |